STOCK TITAN

F5 (NASDAQ: FFIV) CEO sells 3,783 shares under 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

F5, INC. President, CEO & Director Francois Locoh-Donou sold shares of FFIV common stock in multiple open-market transactions on May 5, 2026 under a Rule 10b5-1 trading plan. He sold a total of 3,783 shares at prices ranging from $332.05 to $340.27 per share. Following these sales, he directly holds 150,732 common shares and also reports 42,000 shares held indirectly through a family trust for his children, where his spouse serves as trustee.

Positive

  • None.

Negative

  • None.
Insider Locoh-Donou Francois
Role President, CEO & Director
Sold 3,783 shs ($1.28M)
Type Security Shares Price Value
Sale Common Stock 40 $331.05 $13K
Sale Common Stock 200 $332.522 $67K
Sale Common Stock 80 $335.275 $27K
Sale Common Stock 1,332 $336.9244 $449K
Sale Common Stock 1,268 $337.7807 $428K
Sale Common Stock 480 $338.6025 $163K
Sale Common Stock 383 $339.8752 $130K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 150,732 shares (Direct, null); Common Stock — 42,000 shares (Indirect, By Family Trust)
Footnotes (1)
  1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 12/03/2025. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $332.05 to $332.98. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $334.99 to $335.56. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $336.35 to $337.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $337.35 to $338.24. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $338.38 to $339.04. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $339.51 to $340.27. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. These shares are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust.
Shares sold 3,783 shares Total common shares sold on May 5, 2026
Sale price range $332.05–$340.27 per share Actual prices received across reported trades
Direct holdings after sale 150,732 shares Common stock directly owned after May 5, 2026 trades
Indirect trust holdings 42,000 shares Common shares held by family trust for children
Number of sale transactions 7 transactions Open-market sales of common stock on May 5, 2026
Trading plan date December 3, 2025 Date of Rule 10b5-1 trading plan governing the sales
Rule 10b5-1 trading plan regulatory
"This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 12/03/2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price in Column 4 is a weighted average sale price."
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
family trust financial
"These shares are held in a trust for the benefit of the reporting person's children."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Locoh-Donou Francois

(Last)(First)(Middle)
C/O F5, INC.
801 5TH AVENUE

(Street)
SEATTLE WASHINGTON 98104

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
F5, INC. [ FFIV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President, CEO & Director
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/05/2026S40(1)D$331.05150,732D
Common Stock05/05/2026S200D$332.522(2)150,532D
Common Stock05/05/2026S80D$335.275(3)150,452D
Common Stock05/05/2026S1,332D$336.9244(4)149,120D
Common Stock05/05/2026S1,268D$337.7807(5)147,852D
Common Stock05/05/2026S480D$338.6025(6)147,372D
Common Stock05/05/2026S383D$339.8752(7)146,989D
Common Stock42,000IBy Family Trust(8)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 12/03/2025.
2. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $332.05 to $332.98. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
3. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $334.99 to $335.56. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
4. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $336.35 to $337.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
5. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $337.35 to $338.24. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
6. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $338.38 to $339.04. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
7. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $339.51 to $340.27. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
8. These shares are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust.
Remarks:
/s/ Angelique M. Okeke by Power of Attorney05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did FFIV CEO Francois Locoh-Donou report?

Francois Locoh-Donou reported selling 3,783 shares of F5 common stock in multiple open-market transactions on May 5, 2026. The sales were executed under a Rule 10b5-1 trading plan, indicating they were pre-arranged rather than timed discretionarily.

At what prices did the FFIV CEO sell his F5, INC. shares?

The reported sales used weighted average prices, with actual prices ranging from $332.05 to $340.27 per share. Each Form 4 line item includes a weighted average price, and footnotes specify the detailed price ranges for the underlying individual trades.

How many F5 (FFIV) shares does the CEO hold after these sales?

After the May 5, 2026 transactions, Francois Locoh-Donou directly holds 150,732 shares of F5 common stock. He also reports 42,000 additional shares held indirectly through a family trust established for his children, with his spouse serving as trustee.

Were the FFIV CEO’s stock sales made under a Rule 10b5-1 plan?

Yes. A footnote states the transactions were executed pursuant to a Rule 10b5-1 trading plan dated December 3, 2025. Such plans allow insiders to pre-schedule trades, reducing the likelihood that the timing reflects non-public information or discretionary market timing.

Does the FFIV CEO have indirect holdings through a trust?

Yes. The Form 4 shows 42,000 F5 common shares held indirectly by a family trust for the benefit of his children. Another footnote explains that the reporting person’s spouse is the trustee of this trust, clarifying the nature of the indirect ownership.

How many sale transactions did the F5 (FFIV) CEO execute on May 5, 2026?

The filing lists seven separate open-market sale transactions of F5 common stock on May 5, 2026. Each line reflects a different block of shares with its own weighted average price, together totaling 3,783 shares sold on that date.